The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil.

[1]  W. Sadee,et al.  Activation of Ftorafur [R,S-1-(Tetrahydro-2-furanyl)-5-fluorouracil] to 5-Fluorouracil and γ-Butyrolactone , 1980 .

[2]  R. Benjamin,et al.  SYNTHESIS AND BIOLOGICAL ACTIVITIES OF FTORAFUR METABOLITES. 3′- AND 4′-HYDROXYFTORAFUR , 1980 .

[3]  W. Sadee,et al.  Pharmacokinetics and metabolism of ftorafur in man. , 1979, Cancer treatment reports.

[4]  R. Benjamin,et al.  Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans. , 1978, Cancer research.

[5]  W. Wolberg,et al.  Pharmacokinetics of fluorouracil in humans. , 1978, Cancer research.

[6]  Yoshimasa Nakamura,et al.  新制癌剤5-Fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione(FD-1)の生体内運命(第1報)経口投与による吸収, 分布, 代謝および排泄 , 1978 .

[7]  N. Unemi,et al.  Studies of antitumor agents. 1. Resolution of racemic 1-(tetrahydro-2-furanyl)-k-fluorouracil into the R and S isomers and examination of the biological activities of the isomers. , 1977, Journal of medicinal chemistry.

[8]  R. Freudenthal,et al.  The metabolism of ftorafur in the beagle dog and rhesus monkey. , 1977, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  W. Sadee,et al.  Pharmacokinetics of 5-Fluorouracil: Inter-relationship with Biochemical Kinetics in Monitoring Therapy , 1977, Clinical pharmacokinetics.

[10]  W. Brukwiński,et al.  GLC determination for ftorafur in biological fluids. , 1977, Journal of pharmaceutical sciences.

[11]  Meĭrena Dv,et al.  [Pharmacokinetics of ftorafur-2-14C in rats with Walker carcinosarcoma]. , 1977 .

[12]  J. Benvenuto,et al.  High-pressure liquid chromatographic analysis of ftorafur and its metabolites in biological fluids. , 1977, Journal of chromatography.

[13]  A. Goldin,et al.  Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. , 1976, Cancer treatment reports.

[14]  A. Goldin,et al.  Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice. , 1976, Cancer treatment reports.

[15]  R. Diasio,et al.  Pharmacokinetics of the fluoropyrimidines: implications for their clinical use. , 1976, Cancer treatment reviews.

[16]  T. Vree,et al.  Rapid determination of 4-hydroxybutyric acid (Gamma OH) and 2-propyl pentanoate (Depakine) in human plasma be means of gas-liquid chromatography. , 1976, Journal of chromatography.

[17]  W. Sadee,et al.  Determination of ftorafur and 5-fluorouracil levels in plasma and urine. , 1976, Research communications in chemical pathology and pharmacology.

[18]  E. Freireich,et al.  Clinical evaluation of ftorafur (pyrimidine-deoxyribose n1-2'-furanidyl-5-fluorouracil). , 1976, Cancer research.

[19]  J. Rosenfeld,et al.  Letter: Blood levels of 5-fluorouracil during intravenous infusion. , 1976, British Journal of Cancer.

[20]  A. M. Cohen.  The disposition of ftorafur in rats after intravenous administration. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[21]  節郎 藤井,et al.  制癌剤1-(2-Tetrahydrofuryl)-5-fluorouracil(FT一207), の生体内運命(第3報)直腸内投与による吸収, 体内分布, 排泄および代謝 , 1975 .

[22]  D. Kessel,et al.  In vitro biological evaluation of the R and S isomers of 1-(Tetrahydrofuran-2-yl)-5-fluorouracil. , 1975, Cancer research.

[23]  W. Sadee,et al.  Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography. , 1975, Cancer chemotherapy reports.

[24]  R. Zhuk,et al.  Analogs of pyrimidine nucleosides , 1974 .

[25]  A. Garin,et al.  Results of treatment of malignant tumors with ftorafur , 1972, Cancer.

[26]  A. Burger.  Design of Active-Site-Directed Irreversible Enzyme Inhibitors. , 1967 .

[27]  Giller Sa,et al.  [Analogs of pyrimidine nucleosides. I. N1-(alpha-furanidyl) derivatives of natural pyrimidine bases and their antimetabolities]. , 1967 .

[28]  Greenwald Es.  Cancer chemotherapy. II. , 1966 .

[29]  J. Jacquez.  Permeability of Ehrlich Cells to Uracil, Thymine and Fluorouracil.∗ , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  R. Cleeland,et al.  5'-deoxy-5-fluorouridine-a New orally active antitumor agent. Comparative activity with 5-fluorouracil, 2'- deoxy-5-fluorouridine and ftorafur against transplant- able tumors in mice and rats. Abstr. , 1979 .

[31]  J. Seitz,et al.  Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics. , 1979, Bulletin du cancer.

[32]  R. Diasio,et al.  5'-Deoxy-5-fluorouridine: Cellular metabolism of a new fluoropyrimidine with antineoplastic activity , 1979 .

[33]  R. Diasio,et al.  Pharmacologic study of oral ftorafur: Potential for improved oral delivery of 5-fluorouracil , 1979 .

[34]  S. Spiegelman,et al.  Mechanism of action of 5-fluorouracil (fu) in the chemotherapy of the murine mammary tumor. Abstr. , 1979 .

[35]  W. Sadee,et al.  Hydroxylated Metabolites of R,S-1-(Tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in Rats and Rabbits , 1978 .

[36]  S. Fujimoto,et al.  Effect of N1-(2'-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on nucleic acid and protein biosyntheses in Ehrlich ascites cells. , 1976, Cancer research.

[37]  R. Benjamin,et al.  Pharmacokinetics and metabolism of ftorafur (FT) in man , 1976 .

[38]  K. Kitada,et al.  Experimental Approach to Increase the Effects of Cancer Chemotherapy in Tumor-Bearing Rats Pretreated with an Inducer on Microsomal Drug-Metabolizing Enzyme (cytochrome p-450) , 1976 .

[39]  Karev Ni,et al.  Experience with ftorafur treatment in breast cancer. , 1972 .

[40]  Smolyanskaya Az,et al.  To biological activity of antitumour antimetabolite "ftorafur". , 1972 .